Results 61 to 70 of about 6,017,180 (335)

Sirolimus for Extracranial Arteriovenous Malformations: A Scoping Review of the Evidence in Syndromic and Non‐Syndromic Cases

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Arteriovenous malformations (AVMs) are rare, high‐flow, vascular anomalies that can occur either sporadically or as part of a genetic syndrome. AVMs can progress with serious morbidity and even mortality if left unchecked. Sirolimus is an mTOR inhibitor that is effective in low‐flow vascular malformations; however, its role in AVMs is unclear.
Will Swansson   +3 more
wiley   +1 more source

METHODS AND MODELS OF DECISION-MAKING IN UNCERTAIN CONDITIONS

open access: yesКомпютерні системи та інформаційні технології, 2022
Were considered the issues of making managerial decisions in uncertain conditions with classical criteria approach for estimation of alternatives from a set of possible decision-making variants.
TETIANA SICHKO   +2 more
doaj   +1 more source

An ES process framework for understanding the strategic decision making process of ES implementations [PDF]

open access: yes, 2001
Enterprise systems (ES) implementations are regarded costly, time and resource consuming and have a great impact on the organization in terms of the risks they involve and the opportunities they provide. The steering committee (SC) represents the group
Shakir, Maha
core  

Evaluating the Utility of Paired Tumor and Germline Targeted DNA Sequencing for Pediatric Oncology Patients: A Single Institution Report

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate the diagnostic yield and utility of universal paired tumor–normal multigene panel sequencing in newly diagnosed pediatric solid and central nervous system (CNS) tumor patients and to compare the detection of germline pathogenic/likely pathogenic variants (PV/LPVs) against established clinical referral criteria for cancer ...
Natalie Waligorski   +9 more
wiley   +1 more source

Information and participation in decision-making about treatment: a qualitative study of the perceptions and preferences of patients with rheumatoid arthritis. [PDF]

open access: yes, 2008
Objectives: To elicit the perceptions and preferences of patients with rheumatoid arthritis regarding information and participation in treatment decision-making.
Grünke, Mathias   +3 more
core   +1 more source

Preferences of Pediatric Patients and Their Caregivers for Chemotherapy‐Induced Nausea and Vomiting Control Endpoints: A Mixed Methods Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Although not always achieved, complete chemotherapy‐induced nausea and vomiting (CINV) control is the conventional goal of CINV prophylaxis. In this two‐center, mixed‐methods study, we sought to understand the preferences of adolescent patients and family caregivers for CINV control endpoints.
Haley Newman   +8 more
wiley   +1 more source

DECISION MAKING MODELS AND ALGORITHMS IN SITUATIONS OF UNCERTAINTY [PDF]

open access: yesEconomica, 2019
This study describes three decision making models for uncertain situations, when the decision maker has infinity of alternatives, the activity is determined by uncontrollable factors, and the number of states of nature is ...
Lilian GOLBAN, Anatol GODONOAGĂ
doaj  

Neural Models of Motion Integration, Segmentation, and Probablistic Decision-Making [PDF]

open access: yes, 2007
When brain mechanism carry out motion integration and segmentation processes that compute unambiguous global motion percepts from ambiguous local motion signals? Consider, for example, a deer running at variable speeds behind forest cover.
Grossberg, Stephen
core   +1 more source

Collaborative model development increases trust in and use of scientific information in environmental decision-making [PDF]

open access: yes, 2018
While science matters for environmental management, creating science that is credible, salient to decision-makers, and deemed legitimate by stakeholders is challenging.
Ulibarri, N
core   +1 more source

Intravitreal GD2‐Specific Chimeric Antigen Receptor T‐Cell Therapy for Refractory Retinoblastoma

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Effective treatments for advanced, treatment‐resistant retinoblastoma (RB) remain limited. GD2‐specific chimeric antigen receptor (CAR) T cells show potent antitumor activity with minimal toxicity but have not previously been evaluated in RB.
Subongkoch Subhadhirasakul   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy